SeaStar Medical Holding Corporation (ICUCW)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Eric Schlorff | CEO, President & Executive Director | 420k | -- | 1974 |
| Mr. David A. Green CPA, M.B.A. | Chief Financial Officer | 375.6k | -- | 1963 |
| Colonel Kevin Chung FACP, M.D. | Chief Medical Officer | 352.8k | -- | 1973 |
| Dr. H. David Humes M.D. | Co-Founder and Managing Director | 135.71k | -- | -- |
| Mr. Tom Mullen | Vice President of Operations & Product Development | -- | -- | -- |
| Mr. Tim Varacek | Senior VP of Commercial & Business Operations | -- | -- | -- |
| Mr. Sai P. Iyer Ph.D. | Senior Vice President of Medical Affairs & Research | -- | -- | -- |
SeaStar Medical Holding Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 19
Description
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available